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via the Rochester Epidemiology Project was reviewed to determine incident status. Per- 
sons with incident MI were stratified according to use of secondary prevention programs, 
Logistic regression examined the association between use of secondary prevention and 
sex, while adjusting for potential confounders including the cardiovascular risk factors 
and other baseline charactadstics. 
Results: A total of 1657 persons with incident MI were identified, 57% of these were 
men. Overall 733 persons participated in secondary prevention programs, while 827 did 
not. The odds ratio (95% CI) for use of secondary prevention for men versus women was 
2.7 (2,16-3.29). This association did not appear confounded by age, year of incident MI, 
hypertension, smoking, hyperlipidemia, family history of CAD, Killip class, body mass 
index, and comorbidity. 
Conclusion: In Olmsted County MN, women are less likely than men to participate in 
secondary prevention programs after an MI even after taking into account differences in 
risk factors and comorbidity. Further studies are needed to define the underlying cause of 
this association, as well as its long-term impact on subsequent outcomes and to identity 
preventive measures. 
1191-168 Waist  C i rcumference  as Defined by the  Nat ional  
Cholestero l  Education Program Is a Predictor  of  All- 
Cause Morta l i ty  in Women 
Ravish Sachar, Adrian Messedi, Gregory L. Peace, Dennis L. Sprscher, The Cleveland 
Clinic Foundation, Cleveland, Ohio. 
Background: The relationship between obesity and mortality remains controversial. 
Measures of obesity have traditionally included BMI, waist to hip ratio (WHR), and waist 
circumference (WC). The new National Cholesterol Education Program (NCEP) guide- 
lines include WC rather than BMI as the measure of obesity for identification of the meta- 
bolic syndrome. Different cut points were used for men (>102 cm) and women (>88 cm) 
to define obesity. In order to examine the predictive value of the new guidelines, we 
investigated the relationship of WC to the presence of coronary artery disease (CAD) and 
all-cause mortality in men and women. Methods: Among a total of 3627 patients, 2307 
men and 1220 women had BMI, WHR, and WC recorded at baseline and were followed 
for an average of 36 months. Cross-sectional (RR) and longitudinal analyses (HR) were 
performed in those with CAD (men n=1476, 64%), and (women n=505, 41.4%) at base- 
line, and on those without CAD. There were a total of 93 (2.6%) deaths, with 65 (2.8%) 
deaths among men and 28 (2.2%) deaths among women. Results: Using the NCEP 
waist cut points, the unadjusted gender specific relative risk of CAD was 1.33 (95% 
C1=1.13-1.58) among men and 1.57 (95% C1=1.25-1.98) among women. The unadjusted 
gender specific HR for all-cause mortality was 1,29 (95% C1=0.79-2,10) among men and 
4.81 (95% C1=1.66-13.91) among women. After adjusting for age, gender, low HDL, DM, 
and HTN, WC greater than 88 cm in women remained the only significant predictor of 
higher all-cause mortality (RR=3.57, 95% C1=1.20-10.66, p=0.02). Unadjusted WHR was 
found to be predictive of CAD (RR=2.01, 95% C1=1.71-2.36) and mortality (RR=1.64, 
95% C1=1.05-2.55), but neither WHR nor BMI were significant predictors in an adjusted 
model. Conclusions: While a large WC was not an independent predictor of CAD pres- 
ence on cross-sectional review, WC was a significant and independent predictor of all- 
cause mortality in women on follow-up. WC is a better marker than BMI or WHR for pre- 
dicting all cause mortality in women, 
1191-169 Assoc ia t ion  Between Gender  and Fai l ing to  Return to  
Ful l -Time Work  Af ter  CABG 
Jerome L. Abramson, Harlan M. Krumholz, Zhen Qiu Lin, Sally Roumanis, Jennifer 
Mattera, Viola Vaccarino, Emory Universi~ Atlanta, Georgia, Yale Universi~ New 
Haven, ConnecticuL 
Background: The question of whether gender is associated with returning to full time 
work after CABG has not been investigated thoroughly in the U.S. We examined whether 
women were more or less likely than men to resume their pro-operative full time jobs six 
months after undergoing a first CABG at a large urban hospital. 
Methods: The study population included 44 women and 333 men who underwent CABG 
and who were working at a full-time job in the month before the hospitalization for CABG. 
The main predictor variable was gender, and the main outcome variable was failure to 
resume full time work within 6 months after the CABG procedure. Multivariable logistic 
regression was used to determine whether gender was associated with the failure to 
resume full time work, independent of 19 other medical and quality of life factors. 
Results: Compared to men, women who underwent CABG were slightly older and were 
more likely to have a history of hypertension and heart failure. Women were also more 
likely to have left main stenosis of > 90%, insulin-treated diabetes, to have been hospital- 
ized in the past year, and to have a non-elective CABG. Depression levels were higher in 
women at the time of the CABG procedure, and quality of life was lower as reflected by 
lower scores on the physical and mental component scales of the SF-36. Six months 
after the CABG procedure 22 (50.0%) of the 44 women had failed to return to full-time 
work while 89 (26.7%) of the 333 men had failed to resume full-time work. In a logistic 
regression model, females had a significantly higher odds of not resuming work when 
compared to men (female to male odds ratio 2.10; 95% C I 1.10-4.19; p = .05), indepen- 
dent of other baseline factors that were significantly associated with the outcome (age, 
history of MI, left ventricular ejection fraction, physical and mental component scales of 
the SF-36). 
Conclusion: Compared to men, women are less likely to resume full-time work six 
months after undergoing a first CABG. Further study is required to determine the reasons 
for this gender difference. 
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1191-170 Do Hot Flashes Explain the Protective Association 
Between HRT and CAD in Woman: The NHLBI- 
Sponsored WISE Study 
c. Noel Bairev.Merz. B. Delia Johnson, Vera Bittner, Barry L. Sharaf, Steven E. Reis, 
Nathaniel Relohek, William Rogers, Carl J. Pepine, George Sopko, Cedars-SinaiMedical 
Center, Los Angeles, California, University of Pittsburgh, Pittsburgh, Pennsylvania. 
Background. The 30-40% prevalence of hot flashes in peri/postmenopeusal women 
may be an indicator of adequate vasomotor eserve, and may explain the apparent pro- 
tective HRT effect (most commonly prescribed for hot flashes) for CAD observed in epi- 
demiological study, but not replicated in randomized, clinical trials. Methods. We studied 
738 participants enrolled in the Women's Ischemia Syndrome Evaluation (WISE) study 
undergoing coronary angiography for suspected myocardial isohemia. Subgroups under- 
went brachial artery reactivity (BART)(n=214) and coronary acetylcholine (ACH)(n=83) 
testing. Results. Overall, the 504 (68%) women reporting a history of hot flashes were 
younger (60-J:9 vs 64+10 yrs, p=0.0001, respectively) compared to women without hot 
flashes. These women were more likely to take HRT and had less CAD (Table). Assess- 
ment of BART and ACH results, following adjustment for age, CAD status and current 
HRT use demonstrated no group differences. Multivariate regression modelling that 
included age, HRT use and history of hot flashes, age was the best predictor of anglo- 
graphic CAD (p--0.0001), while absence of hot flashes was a moderate predictor 
(p=0.08). Conclusions. Among women undergoing coronary angiography for suspected 
myocardial ischemia, a history of hot flashes is associated with greater HRT use and less 
angiographic CAD. This suggests that hot flashes, possibly a measure of adequate vaso- 
motor reserve, may explain the apparent observed benefit of HRT for CAD in women. 
No Hot Flashes Hot Flashes p 
N 234 504 
Current HRT (%) 32 50 0,001 
Prior HRT (%) 9 16 0.02 
CAD (>50%X%) 50 36 0.001 
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861-1 Is Early Hospital Discharge Following Acute Myocardial 
Infarction Associated With Increased Morta l i ty?  
Alan K. Bemer. Susan J. Duval, Russell V. Luepker, University of Minnesota, 
Minneapolis, Minnesota. 
Background: There has been a steady decrease in beth short and long-term mortality follow- 
ing acute myocardial infarction during the past 15 years. The presumption of a prolonged 
survival in the early phase of an acute myocardial infarction along with economic constraints 
has led to a progressively shorter length of hospital stay. Hypothesis: We sought to deter- 
mine whether there was an associaflon between decreasing hospital length of stay and 
early post-discharge mortality following acute myocardial infarction. Methods: The Minne- 
sota Heart Survey, developed in 1970, is a hospital surveillance project designed to assess 
the incidence and prevalence of acute myocardial infarction and trends in health cars pro- 
cess and outcomes, The essential component is a large database of medical record 
abstractions of patients hospitalized in the Minneapolis metropolitan area with acute myo- 
cardial infarction. Surveys from 1985, 1990 and 1995 were utilized in this study to assess 
Vends in early and iata mortality, case fatality, and hospital ength of stay. Trends across sur- 
vey years wore compared using the chi-square statistic. Continuous data were expressed 
as mean ± standard deviation and compared with the KruskaI-Wallis test. Results: 4516 
patients with validated acute myocardial infarction were identified from the combined 1985 
(n=1354), 1990 (n=1763) and 1995 (n=1399) surveys. In-hospital case fatality declined from 
12.3% in 1985, to 10.3% in 1990, to 7.7% in 1995 (p=0.0003). Thirty-day crude mortality for 
1985, 1990 and 1995 was 13,8%, 12.1% and 8.4%, rsspec~vely (p<0.0001). The mean 
length of stay for these same time frames were 11.3 ± 8.0, 9.5 ± 7.2 and 7.5 ± 6.2 days. The 
7-day post-discharge mortality rates were 1.03% (n=14), 1,53% (n=27), and 0.43% (n--6); 
no Vend was demonstrable by the Cochran-Armitsge test (p-~.11). Conclusion: In spite of 
the reduction in hospital length of stay following acute myocardial infarction, there has not 
been an associated increase in eady post-discharge mortality. 
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861-2 IS There  a Role for  Troponin- I  in the  Risk Strat i f icat ion 
of Stable AsymptomaUc Hemodialysis Patients? 
Michael E, Farkouh, Michael J. Robbins, M. Ureoi Zafar. Dalohi Shimbo, Jonathan L. 
Halperin, Karina Davidson, Rupe Volate, Edward M, Epstein, Mayank Patel, Zvi Tator, 
James H. Chesebro, Mount Sinai School of Medicine, New York, New York, Saint Johns- 
Queens Hospital, Queens, New York. 
Backoround: Patients on hemodialysis have a high mortality rate pdmadly due to cardio- 
vascular events. Evidence suggests that troponin-I (cTnl) levels may have a role in predict- 
ing these adverse cardiovascular events. 
Methods: All chronic hemodialysis patients at two teaching hospitals in New York were fol- 
